Caribou Biosciences

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell CRBU and other ETFs, options, and stocks.

About CRBU

Caribou Biosciences, Inc. engages in the development of an internal pipeline of off-the-shelf CAR-T and CAR-NK cell therapies. Its tools and technologies provide transformative capabilities to basic and applied biological research, therapeutic development, agricultural biotechnology, and industrial biotechnology. 

CEO
Rachel E. Haurwitz
CEORachel E. Haurwitz
Employees
147
Employees147
Headquarters
Berkeley, California
HeadquartersBerkeley, California
Founded
2011
Founded2011
Employees
147
Employees147

CRBU Key Statistics

Market cap
96.72M
Market cap96.72M
Price-Earnings ratio
-0.65
Price-Earnings ratio-0.65
Dividend yield
Dividend yield
Average volume
868.86K
Average volume868.86K
High today
$1.06
High today$1.06
Low today
$0.90
Low today$0.90
Open price
$0.939
Open price$0.939
Volume
1.10M
Volume1.10M
52 Week high
$3.45
52 Week high$3.45
52 Week low
$0.66
52 Week low$0.66

Analyst ratings

78%

of 9 ratings
Buy
77.8%
Hold
22.2%
Sell
0%

People also own

Based on the portfolios of people who own CRBU. This list is generated using Robinhood data, and it’s not a recommendation.
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.